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plastycznym (MDS), a najstabsza w ostrej
biataczce limfoblastycznej (ALL). Nie wy-
kluczone, i:e spostrzegane roi:nice inten-
sywnosci efektu GvL wynikajq z odmiennej
ekspresji antygenow gtownego i tzw.
mniejszego uktadu zgodnosci tkankowej
cztowieka zlokalizowanych na powierzchni
komorek biataczkowych przeciw, kt6rym
skierowane jest dziatanie kom6rek efek-
torowych GvL. Prowadzone Sq badania
dotyczqce optymalnej liczby Iimfocyt6w
CD3+ podawanych w infuzji, odst~pu
miE2dzy kolejnymi infuzjami, kojarzenia DLI
z podawaniem niekt6rych cytokin oraz op-
tymalizowania immunoterapii w zalei:nosci
od wynik6w molekularnych badan chime-
ryzmu i poziomu choroby resztkowej.
Pr6buje siE2 zidentyfikowac czynniki pro-
gnostyczne, ktore pozwolityby przewidy-
wac zar6wno odpowiedi: na DLI,
jak i ryzyko wystqpienia powiktan zWiqza-
nych z jej podaniem, zwtaszcza GvHD.
Podejmowane Sq pr6by selekcji i/lub ge-
neracji swoistych Iimfocyt6w CD3 wyka-
zujqcych silny efekt przeciwbiataczkowy,
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A recent EU Directive on medical ra-
diation exposures includes a requirement
for Clinical Audit of all such processes.
Flexibility was given for this to be carried
out 'in accordance with national proce-
dures'. Whilst clinical audit in radiotherapy
must cover the whole range of processes
from referral to follow-up, one critical part
of audit is that of delivered doses to
patients; both at the level of the individual
patient (to include internal audit, dose
verification, in vivo dosimetry) and at the
level of the institution (to include sys-
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tematic assessments of dose accuracy
and precision and also external audit).
Audit must be against accepted evidence-
based standards. For conventional radio-
therapy, techniques are well established
for such dosimetric stUdies. As regards
internal audit (or dose verification) some
results and observations are given from
the 10-year experience of systematic use
of diodes for in vivo dosimetry in the
Edinburgh Cancer Centre As regards
external audit, there are a range of
national and international systems carrying
out measurements, some based on site
visits (e.g. Finland, UK) and some based
on mailed TLD (e.g. Poland, ESTRO-
EQUAL). Methods and results are illu-
strated by considering the UK audit
network and the ESTRO-EQUAL system.
Currently, new technology is being rapidly
introduced and implemented in radiothe-
rapy departments. This includes some
newer designs of treatment equipment,
such as tomotherapy and robotic systems;
non-standard beams and treatment
techniques, such as IMRT and image-
gUided techniques. These introduce new
problems for dose verification and for
external audit, requiring more complex
measurement methods..Specifically they
require at least 2-dimensional and
integrating methods to cope with varying
intensity beams and dynamic delivery.
Single point methods are no longer
sufficient. Some requirements for these
applications are discussed. Some methods
and results are considered from the
development and implementation of film-
based approaches to dose verification and
for external audits and also from initial
studies of aSi EPIDs for dose verification
and for in vivo dosimetry. Conclusions can
be drawn from the evid.enceb,a.~e9f tbese
results on what accuracy is achievable in
radiotherapy dosimetry within a given
department and between departments.
This can be used to help to inform
decisions and strategies for the use of
IMRT and other complex technologies.
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